{"component": "definition", "props": {"groups": [{"samples": [{"hash": "jtD5lhEQYHw", "uri": "/contracts/jtD5lhEQYHw#fff", "label": "Iru Agreement (Winstar Communications Inc)", "score": 18.0, "published": true}, {"hash": "9QDZZp6XIf4", "uri": "/contracts/9QDZZp6XIf4#fff", "label": "Iru Agreement (Winstar Communications Inc)", "score": 18.0, "published": true}, {"hash": "9Msg412cB5k", "uri": "/contracts/9Msg412cB5k#fff", "label": "Iru Agreement (Winstar Communications Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "the-\u2587", "type": "clause", "offset": [35, 40]}, {"key": "points-of-presence", "type": "definition", "offset": [77, 95]}], "snippet": "On Net\" means a Circuit traversing the \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Network between two \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 points of presence.", "size": 3, "hash": "5a9f60f2b031f05e7be364bea6731a51", "id": 1}, {"samples": [{"hash": "kE4UvyQgOqp", "uri": "https://unece.org/DAM/trans/doc/2018/sc1/ECE-TRANS-SC1-GE21-INF-OCT-2018-1ef_01.pdf", "label": "Agreement", "score": 13.1177275838, "published": false}, {"hash": "dwLXV0dfogQ", "uri": "https://www.legislation.gov.uk/eur/2018/502/pdfs/eur_20180502_adopted_en.pdf", "label": "www.legislation.gov.uk", "score": 9.1177275838, "published": false}, {"hash": "ivy7PDRRkS6", "uri": "https://dtc.jrc.ec.europa.eu/iot_doc/EU%202018-502.pdf", "label": "dtc.jrc.ec.europa.eu", "score": 9.1177275838, "published": false}], "snippet_links": [{"key": "accumulated-driving-time", "type": "definition", "offset": [0, 24]}], "snippet": "accumulated driving time\u201d means:", "size": 3, "hash": "1e143cd20c26f29237cd0fe00bfc5196", "id": 2}, {"samples": [{"hash": "h6ZsW2niwZI", "uri": "/contracts/h6ZsW2niwZI#fff", "label": "Separation and Distribution Agreement (Triple Crown Media, Inc.)", "score": 18.0, "published": true}, {"hash": "gQyXW8QgZcQ", "uri": "/contracts/gQyXW8QgZcQ#fff", "label": "Merger Agreement (Bull Run Corp)", "score": 18.0, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [18, 33]}, {"key": "specified-person", "type": "definition", "offset": [38, 54]}, {"key": "limited-liability-company", "type": "definition", "offset": [77, 102]}, {"key": "legal-entity", "type": "definition", "offset": [134, 146]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [194, 216]}, {"key": "the-stock", "type": "clause", "offset": [235, 244]}, {"key": "other-equity-interest", "type": "definition", "offset": [248, 269]}, {"key": "entitled-to-vote", "type": "clause", "offset": [270, 286]}, {"key": "election-of", "type": "clause", "offset": [294, 305]}, {"key": "members-of-the-board-of-directors", "type": "clause", "offset": [310, 343]}, {"key": "governing-body", "type": "definition", "offset": [355, 369]}, {"key": "the-context", "type": "clause", "offset": [378, 389]}, {"key": "reference-to", "type": "clause", "offset": [410, 422]}], "snippet": "Subsidiary\" means with respect to any specified Person, any corporation, any limited liability company, any partnership, or any other legal entity of which such Person or its Subsidiaries owns, directly or indirectly, more than 50% of the stock or other equity interest entitled to vote on the election of the members of the board of directors or similar governing body. Unless the context otherwise requires, reference to \u2587\u2587\u2587\u2587 and its Subsidiaries shall not include \u2587\u2587\u2587\u2587 Publishing and its Subsidiaries, and those subsidiaries will be treated as Subsidiaries of TCM.", "size": 3, "hash": "317dbecef96ab5c1b1d840338d79e32d", "id": 3}, {"samples": [{"hash": "g9TEWOQs4L0", "uri": "http://www.goaprintingpress.gov.in/downloads/1011/1011-22-SI-OG.pdf", "label": "www.goaprintingpress.gov.in", "score": 5.3244353183, "published": false}, {"hash": "5xnkNANMB4w", "uri": "https://goaprintingpress.gov.in/downloads/0910/0910-38-SI-OG.pdf", "label": "goaprintingpress.gov.in", "score": 3.0, "published": false}], "snippet_links": [{"key": "the-government", "type": "definition", "offset": [105, 119]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [155, 173]}], "snippet": "jetty\u201d means any structure or platform made of either concrete or steel, which is erected/constructed in the Government Riverine Land along the river bank for the purpose of loading/", "size": 3, "hash": "22c0b00954ade9b1923c7a1220d2f5e7", "id": 4}, {"samples": [{"hash": "b5iKpqBwMfM", "uri": "/contracts/b5iKpqBwMfM#fff", "label": "Iru Agreement (Williams Communications Group Inc)", "score": 18.0, "published": true}, {"hash": "2iuB3uMaZco", "uri": "/contracts/2iuB3uMaZco#fff", "label": "Iru Agreement (Williams Communications Group Inc)", "score": 18.0, "published": true}], "snippet_links": [], "snippet": "On Net\" means a Circuit traversing the Will\u2587\u2587\u2587\u2587 \u2587\u2587\u2587work between two Will\u2587\u2587\u2587\u2587 \u2587\u2587\u2587nts of presence.", "size": 2, "hash": "47423ba0be029ef4d493ebe7694f0e19", "id": 5}, {"samples": [{"hash": "9Z3XvvUIMP5", "uri": "/contracts/9Z3XvvUIMP5#fff", "label": "Strategic Alliance Agreement (Siebert Financial Corp)", "score": 18.0, "published": true}], "snippet_links": [{"key": "profitability-date", "type": "definition", "offset": [0, 18]}, {"key": "day-of", "type": "clause", "offset": [35, 41]}, {"key": "the-joint", "type": "clause", "offset": [76, 85]}, {"key": "brokerage-service", "type": "definition", "offset": [86, 103]}, {"key": "operating-profit", "type": "definition", "offset": [120, 136]}], "snippet": "Profitability Date\" means the last day of the first True-Up Period in which the Joint Brokerage Service has achieved an Operating Profit.", "size": 1, "hash": "07f024f7a0d0de1e73d1186a5cd771cb", "id": 6}, {"samples": [{"hash": "4WEcrfOknhf", "uri": "http://www.pas.gov.pk/uploads/acts/Sindh%20Act%20No.VIII%20of%202009%20THE%20LARKANA%20DEVELOPMENTAUTHORITY%20(REVIVAL%20AND%20AMENDING)%20ACT,%202009.pdf", "label": "www.pas.gov.pk", "score": 8.1704312115, "published": false}], "snippet_links": [{"key": "section-2", "type": "definition", "offset": [42, 51]}, {"key": "local-government-ordinance", "type": "definition", "offset": [65, 91]}], "snippet": "District\u201d means District as defined under section 2 of the Sindh Local Government Ordinance, 2001.\u201d;", "size": 1, "hash": "ab37e1396ad4e7ed9653fe4247f05670", "id": 7}, {"samples": [{"hash": "fI8515V8RP0", "uri": "/contracts/fI8515V8RP0#fff", "label": "Gas Sales Contract (Boston Gas Co)", "score": 18.0, "published": true}], "snippet_links": [{"key": "cost-difference", "type": "definition", "offset": [5, 20]}], "snippet": "Unit Cost Difference\"; and Section", "size": 1, "hash": "b57971d718907473b8890a8a686b07cf", "id": 8}, {"samples": [{"hash": "ii5QdmFPPs6", "uri": "/contracts/ii5QdmFPPs6#fff", "label": "Asset Purchase Agreement (Shire Pharmaceuticals Group PLC)", "score": 18.0, "published": true}], "snippet_links": [{"key": "the-security-agreement", "type": "clause", "offset": [16, 38]}, {"key": "granted-by", "type": "definition", "offset": [39, 49]}, {"key": "title-and-interest", "type": "clause", "offset": [131, 149]}, {"key": "from-time-to-time", "type": "clause", "offset": [150, 167]}, {"key": "the-intellectual-property-rights", "type": "clause", "offset": [178, 210]}, {"key": "product-registrations", "type": "clause", "offset": [216, 237]}, {"key": "regulatory-approvals", "type": "definition", "offset": [242, 262]}, {"key": "in-respect-of", "type": "clause", "offset": [263, 276]}, {"key": "the-research", "type": "clause", "offset": [277, 289]}, {"key": "clinical-testing", "type": "clause", "offset": [304, 320]}, {"key": "sale-of", "type": "clause", "offset": [349, 356]}, {"key": "pipeline-products", "type": "clause", "offset": [361, 378]}, {"key": "all-claims", "type": "clause", "offset": [380, 390]}, {"key": "all-rights", "type": "clause", "offset": [408, 418]}, {"key": "contracts-of-sale", "type": "definition", "offset": [453, 470]}, {"key": "use-and-license", "type": "clause", "offset": [499, 514]}, {"key": "the-foregoing", "type": "definition", "offset": [574, 587]}, {"key": "to-secure", "type": "clause", "offset": [589, 598]}, {"key": "obligations-to-pay", "type": "clause", "offset": [605, 623]}, {"key": "amounts-to-be-paid", "type": "clause", "offset": [628, 646]}, {"key": "schedule-d", "type": "definition", "offset": [743, 753]}, {"key": "springing-lien", "type": "definition", "offset": [796, 810]}, {"key": "prior-to-the", "type": "clause", "offset": [885, 897]}, {"key": "at-the-time", "type": "clause", "offset": [918, 929]}, {"key": "the-security-interest", "type": "clause", "offset": [944, 965]}, {"key": "to-file", "type": "definition", "offset": [1006, 1013]}, {"key": "financing-statement", "type": "clause", "offset": [1016, 1035]}, {"key": "in-relation-to", "type": "clause", "offset": [1036, 1050]}, {"key": "springing-collateral", "type": "definition", "offset": [1056, 1076]}], "snippet": "Security\" means the security agreement granted by IDB to Shire pursuant hereto creating a security interest in all of IDB's right, title and interest from time to time in and to the Intellectual Property Rights, all product registrations and regulatory approvals in respect of the research, development, clinical testing, manufacture, promotion and sale of any Pipeline Products, all claims arising from and all rights, title and interest of IDB in all contracts of sale, distribution, manufacture, use and license of any of the Pipeline Products and all proceeds of any of the foregoing, to secure IDB's obligations to pay the amounts to be paid pursuant hereto and to perform its obligations hereunder, substantially in the form attached as Schedule D hereto. The Security shall also contain a springing lien condition such that if IDB does not pay the amount due under Section 5.15 prior to the Time of Attachment, at the Time of Attachment the security interest shall attach to, and Shire will be able to file a financing statement in relation to, the Springing Collateral.", "size": 1, "hash": "5ad9b18c1115d411be1ec2e62f18b35b", "id": 9}, {"samples": [{"hash": "jafzZaJsXMe", "uri": "/contracts/jafzZaJsXMe#fff", "label": "Exclusive License Agreement (Lexicon Pharmaceuticals, Inc.)", "score": 33.1786447639, "published": true}], "snippet_links": [{"key": "an-individual", "type": "clause", "offset": [15, 28]}, {"key": "pharmacovigilance-agreement", "type": "definition", "offset": [122, 149]}, {"key": "section-71", "type": "clause", "offset": [180, 191]}, {"key": "authorized-generic-product", "type": "definition", "offset": [372, 398]}, {"key": "in-the-field", "type": "clause", "offset": [436, 448]}, {"key": "promotional-materials", "type": "definition", "offset": [457, 478]}, {"key": "and-information", "type": "clause", "offset": [614, 629]}, {"key": "sale-of-the-product", "type": "clause", "offset": [669, 688]}, {"key": "quality-agreement", "type": "clause", "offset": [697, 714]}, {"key": "receiving-party", "type": "definition", "offset": [767, 782]}, {"key": "section-111", "type": "clause", "offset": [813, 825]}, {"key": "regulatory-authority", "type": "definition", "offset": [834, 854]}, {"key": "governmental-body", "type": "clause", "offset": [877, 894]}, {"key": "commercialization-of-the-product", "type": "clause", "offset": [933, 965]}, {"key": "in-the-territory", "type": "clause", "offset": [981, 997]}, {"key": "plans-and", "type": "clause", "offset": [1139, 1148]}, {"key": "other-licensees", "type": "clause", "offset": [1261, 1276]}, {"key": "during-the-term", "type": "clause", "offset": [1286, 1301]}, {"key": "marketing-approval", "type": "definition", "offset": [1344, 1362]}, {"key": "other-indication", "type": "definition", "offset": [1418, 1434]}, {"key": "regulatory-approval", "type": "clause", "offset": [1518, 1537]}, {"key": "outside-the-territory", "type": "clause", "offset": [1538, 1559]}, {"key": "clinical-study-data", "type": "clause", "offset": [1588, 1607]}, {"key": "regulatory-data", "type": "clause", "offset": [1662, 1677]}, {"key": "other-documentation", "type": "clause", "offset": [1707, 1726]}, {"key": "associated-with", "type": "definition", "offset": [1727, 1742]}, {"key": "by-lexicon", "type": "clause", "offset": [1800, 1810]}, {"key": "with-respect-to", "type": "clause", "offset": [1827, 1842]}, {"key": "regulatory-milestone", "type": "clause", "offset": [1863, 1883]}, {"key": "section-62", "type": "clause", "offset": [1914, 1925]}, {"key": "royalty-term", "type": "definition", "offset": [2001, 2013]}, {"key": "period-of-time", "type": "clause", "offset": [2057, 2071]}, {"key": "first-sale", "type": "definition", "offset": [2092, 2102]}, {"key": "permitted-sublicensees", "type": "clause", "offset": [2134, 2156]}, {"key": "section-121", "type": "clause", "offset": [2274, 2286]}, {"key": "but-excluding", "type": "clause", "offset": [2323, 2336]}, {"key": "the-united-states-of-america", "type": "clause", "offset": [2341, 2369]}, {"key": "the-european-union", "type": "clause", "offset": [2393, 2411]}, {"key": "bosnia-and-herzegovina", "type": "clause", "offset": [2457, 2479]}, {"key": "san-marino", "type": "definition", "offset": [2567, 2577]}, {"key": "united-kingdom", "type": "definition", "offset": [2600, 2614]}, {"key": "trade-control-laws", "type": "definition", "offset": [2660, 2678]}, {"key": "type-1-diabetes", "type": "definition", "offset": [2743, 2758]}, {"key": "third-party", "type": "clause", "offset": [2767, 2778]}, {"key": "any-person", "type": "clause", "offset": [2786, 2796]}, {"key": "a-party", "type": "clause", "offset": [2808, 2815]}, {"key": "affiliate-of", "type": "definition", "offset": [2822, 2834]}, {"key": "trade-dress", "type": "definition", "offset": [2983, 2994]}, {"key": "trade-name", "type": "definition", "offset": [2999, 3009]}, {"key": "product-sales", "type": "definition", "offset": [3031, 3044]}, {"key": "section-46", "type": "clause", "offset": [3075, 3086]}, {"key": "valid-claim", "type": "definition", "offset": [3095, 3106]}, {"key": "licensed-intellectual-property", "type": "definition", "offset": [3172, 3202]}, {"key": "competent-jurisdiction", "type": "clause", "offset": [3339, 3361]}, {"key": "time-allowed", "type": "clause", "offset": [3401, 3413]}, {"key": "other-proceeding", "type": "clause", "offset": [3589, 3605]}, {"key": "right-of-appeal", "type": "clause", "offset": [3618, 3633]}, {"key": "pending-claim", "type": "definition", "offset": [3654, 3667]}, {"key": "patent-application", "type": "clause", "offset": [3681, 3699]}], "snippet": "\u201cPerson\u201d means an individual, corporation, company, co-operative, partnership, organization or any similar entity. (ggg) \u201cPharmacovigilance Agreement\u201d has the meaning set forth in Section 7.1. (hhh) \u201cProduct\u201d means sotagliflozin and pharmaceutical dosage forms comprising sotagliflozin, including tablets, in both 200mg and 400mg formulations, both as a branded and as an authorized generic product, including all Improvements, for use in the Field. (iii) \u201cPromotional Materials\u201d means all promotional materials, detail aids and pieces, journal ads, films, artwork and graphics, and any other marketing literature and information used in the marketing, distribution or sale of the Product. (jjj) \u201cQuality Agreement\u201d has the meaning set forth in Section 4.2.3. (kkk) \u201cReceiving Party\u201d has the meaning set forth in Section 11.1. (lll) \u201cRegulatory Authority\u201d means each and every Governmental Body from which approvals are required for Commercialization of the Product in any country in the Territory. (mmm)\u201cRegistration Dossier\u201d means any and all Developmental, scientific, technical or pharmacovigilance documentation (e.g. risk management plans and associated 8 documents) and information, processes, techniques and data in Lexicon\u2019s, its Affiliates\u2019, or their other licensees\u2019 Control during the Term as may be required to obtain and maintain Marketing Approval for the Product in the T1D and CHF indications and any other indication for which Lexicon or any of its Affiliates, or their licensees, applies or obtains regulatory approval outside the Territory, including clinical and non-clinical study data, results, reports (including toxicology reports), and regulatory data, filings, communications and other documentation associated with any regulatory approval outside the Territory Controlled by Lexicon during the Term with respect to the Product. (nnn) \u201cRegulatory Milestone\u201d has the meaning set forth in Section 6.2. (ooo) \u201cRepresentatives\u201d has the meaning set forth in Section 11.2. (ppp) \u201cRoyalty Term\u201d means, on a country-by-country basis, the period of time commencing upon the first sale by Viatris, its Affiliates and permitted sublicensees of the Product in each country in the Territory and continuing until [**]. (qqq) \u201cTerm\u201d has the meaning set forth in Section 12.1. (rrr) \u201cTerritory\u201d means worldwide, but excluding (a) the United States of America and (b) all members of the European Union as of October 4, 2024, and Albania, Andorra, Bosnia and Herzegovina, Iceland, Kosovo, Liechtenstein, Moldova, Monaco, Montenegro, North Macedonia, Norway, San Marino, Serbia, Switzerland, United Kingdom (including Ireland) and Vatican City. (sss) \u201cTrade Control Laws\u201d has the meaning set forth in Section 8.4(a). (ttt) \u201cT1D\u201d means Type 1 Diabetes. (uuu) \u201cThird Party\u201d means any Person other than a Party or an Affiliate of a Party. (vvv) \u201cTrademark\u201d means any word, name or symbol, or any combination thereof, whether registered or unregistered, including any trademark, trade dress, or trade name. (www) \u201cUnauthorized Product Sales\u201d has the meaning set forth in Section 4.6. (xxx) \u201cValid Claim\u201d means: (a) a claim of an issued and unexpired patent within the Licensed Intellectual Property that has not been (i) held permanently revoked, unenforceable, unpatentable or invalid by a decision of a court or Governmental Body of competent jurisdiction, unappealable or unappealed within the time allowed for appeal, (ii) rendered unenforceable through disclaimer or otherwise, (iii) abandoned or (iv) permanently lost through an interference, inter parties review, opposition or other proceeding without any right of appeal or review; or (b) a pending claim of a pending patent application within the Licensed Intellectual Property, where [**].", "size": 1, "hash": "f371f4efe214e6f5563ac32dabee4740", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMZmZmIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "(fff)", "snippet": "On Net\" means a Circuit traversing the \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Network between two \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 points of presence.", "size": 40, "id": "fff", "examples": [], "related": [["ddd", "DDD", "DDD"], ["ff", "FF", "FF"], ["dd", "DD", "DD"], ["q", "(q) ", "(q) "], ["jj", "J&J", "J&J"]], "related_snippets": [], "updated": "2025-07-06T21:58:35+00:00"}, "json": true, "cursor": ""}}